Inclusion Criteria

• Age 18-130 years old.
• Has signed an Informed Consent Form in compliance with 21CFR Part 50: "Protection of Human Subjects."
• Ability to understand study procedures and willingness to comply with follow-up visits for the entire length of the study.

Exclusion Criteria

• Any dermatological disorder, which in the investigators’ opinion, may interfere with the accurate evaluation of the subject’s skin characteristics, except for the conditions associated with sensitive skin or photoaging skin.
• Currently receiving chemotherapy or radiation therapy.
• Currently taking prescription oral retinoids (i.e. isotretinoin)
• Currently on anticoagulation therapy (i.e. warfarin, apixaban)
• Currently taking immunosuppressive or immunomodulatory therapy (i.e. corticosteroids, biologic agents) regardless of indication for therapy
• Inability or unwillingness of individual to give written informed consent or comply with the requirements of the protocol.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/09/2024. Questions regarding updates should be directed to the study team contact.